Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Nov 12, 2024 · 10-Q · 43 days after period end · 0001213900-24-096252
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$11.22M | -$9.86M | -$7.69M | -$10.78M |
| EPS Diluted | -$0.50 | -$0.87 | -$0.68 | -$0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end
